Why GSK (LSE:GSK) Is in Focus After It received a new approval in Japan
Highlights GSK (LSE:GSK) Healthcare GSK plc (LSE:GSK) 1916.50 GBX -39.500 ↓ 2.019% Last Updated at: 2026-07-17T15:40:00Z received a…
GSK (LSE:GSK) approval news tests how blue-chip healthcare absorbs innovation
Highlights A Japanese regulatory decision made Hibsago GSKs first approved chronic hepatitis treatment in any market. The shares…
GSK shares drift despite drug approvals boost
By DAILY MAIL CITY & FINANCE Updated: 08:06 BST, 25 August 2026 Drugs giant GSK saw its shares…
GSK Looks 15.2% Overvalued on GF Value™ Amid Solid Dividend Fund
On August 24, 2026, GSK PLC (NYSE: GSK) announced that the FDA has accepted its supplemental Biologics License…
GSK stock steadies above $50 as FDA backs Tivicay expansion
GSK (ISIN GB0009252882) stock was quoted around the mid-$50 range in late August 2026, with one recent close…
Pharma’s new CEOs to watch
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback.…
GSK appoints Tina Graves as President & General Manager, Canada
MISSISSAUGA, ON, Aug. 26, 2026 /CNW/ — GSK today announced the appointment of Tina Graves as General Manager…
GSK LSE:GSK FTSE 100 Faces A Fresh Test As Pipeline And Ownership News Shapes Sentiment
Highlights GSK is in focus because a fresh overseas medicine approval and the importance of regulatory delivery. Hikma…
GSK Looks 15.2% Overvalued on GF Value™ as Dividend Sustainabili
On August 24, 2026, GSK PLC (NYSE: GSK) announced that the FDA has accepted for priority review its…
GSK (LSE:GSK) Why Are UK Pharma Shares Lagging A Record-Chasing London Market?
Highlights London’s pharmaceutical names drifted lower while the wider market pressed towards record ground. American pricing policy remains…
Shafaq News..Iraq moves to bring GSK, global pharmaceutical firms back
2026-08-26T22:32:19+00:00 font Enable Reading Mode A- A A+ Shafaq News- Abu Dhabi Iraq is seeking to bring major…
GSK Looks 15.2% Overvalued on GF Value™ as Dividend Sustainabili
On August 24, 2026, GSK (NYSE: GSK) announced that Japan’s Ministry of Health, Labour and Welfare approved Hibsago,…